Suchergebnisse - "Wang, Yingdan"

PubPharm (21)

1

Irisin combined index to diagnose central precocious puberty in girls : a cross-sectional study

enthalten in: BMC pediatrics | 2024

von Wang, J. | Tang, Y. | Chen, G. | +4

2

Irisin combined index to diagnose central precocious puberty in girls: a cross-sectional study

enthalten in: BMC pediatrics | 2024

von Wang, J. | Tang, Y. | Chen, G. | +4

3

Modelling of tuberculosis dynamics incorporating indirect transmission of contaminated environment and infectivity of smear-negative individuals : A case study for Xinjiang, China

enthalten in: Acta tropica | 2024

von Gao, C. | Zhang, T. | Liao, Y. | +6

4

Risk factors on surgical compliance and its impact on survival outcomes in meningioma patients : a SEER-based retrospective propensity-score matched analysis

enthalten in: BMC surgery | 2024

von Yang, S. | Teng, H. | Wang, Y. | +3

5

A broadly neutralizing antibody inhibits SARS-CoV-2 variants through a novel mechanism of disrupting spike trimer integrity

enthalten in: Cell research | 2023

von Ma, Y. | Mao, Q. | Wang, Y. | +12

CommentOn: Cell Discov. 2023 Apr 4;9(1):37. - PMID 37015915

6

M2e-specific antibodies protect against influenza PR8 virus in an isotype and route dependent manner

enthalten in: Journal of medical virology | 2023

von Sun, T. | Wang, Y. | Zou, P. | +5

7

A comparative study of three models to analyze the impact of air pollutants on the number of pulmonary tuberculosis cases in Urumqi, Xinjiang

enthalten in: PloS one | 2023

von Wang, Y. | Gao, C. | Zhao, T. | +4

8

M2e‐specific antibodies protect against influenza PR8 virus in an isotype and route dependent manner

enthalten in: Journal of Medical Virology | 2023

von Sun, T. | Wang, Y. | Zou, P. | +5

9

Resistance of SARS-CoV-2 Omicron variant to convalescent and CoronaVac vaccine plasma

enthalten in: Emerging microbes & infections | 2022

von Wang, Y. | Ma, Y. | Xu, Y. | +9

10

Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies

enthalten in: Cell discovery | 2022

von Wang, Y. | Zhang, X. | Ma, Y. | +15